Ullrich G Mueller-Lisse1, Ulrike L Mueller-Lisse. 1. Department of Radiology, Institut fuer Klinische Radiologie, Klinikum der Universitaet Muenchen, Ziemssenstrasse 1, 80336, Munich, Germany. ullrich.mueller-lisse@med.uni-muenchen.de
Abstract
OBJECTIVES: To describe current radiological cross-sectional imaging in the detection and staging of advanced renal cell carcinoma (RCC), defined here as RCC reaching beyond the renal capsule, whether by immediate extension or by metastasis. METHODS: Review and summary of current radiological and urological literature, including original articles and reviews, retrieved from the medical data base "PubMed". RESULTS: Multi-detector-row computed tomography (MDCT) shows a sensitivity of up to 100% and specificity of about 90% for retroperitoneal disease, venous tumour thrombus, and metastasis, but limited accuracy for lymphadenopathy in RCC. Magnetic resonance imaging (MRI) is applied as a problem-solving modality, with particular strength in imaging metastasis to brain and bone. However, dynamic, contrast-enhanced- (DCE-) and arterial-spin-labelling (ASL-) MRI may help to monitor early response to angiogenesis inhibitor drugs. Ultrasonography (US) shows limited capability of identifying retroperitoneal disease, venous tumour thrombus extension, and metastasis. Positron Emission Tomography with 18-fluoro-desoxy-glucose (FDG-PET) demonstrates modest accuracy for metastasis of RCC, with positive studies being suspicious, while negative studies cannot reliably exclude disease. CONCLUSIONS: MDCT represents the diagnostic mainstay for the detection and staging of RCC. In the wake of new systemic therapies for advanced RCC, including angiogenesis inhibitor drugs, monitoring treatment response may become a new task for cross-sectional imaging.
OBJECTIVES: To describe current radiological cross-sectional imaging in the detection and staging of advanced renal cell carcinoma (RCC), defined here as RCC reaching beyond the renal capsule, whether by immediate extension or by metastasis. METHODS: Review and summary of current radiological and urological literature, including original articles and reviews, retrieved from the medical data base "PubMed". RESULTS: Multi-detector-row computed tomography (MDCT) shows a sensitivity of up to 100% and specificity of about 90% for retroperitoneal disease, venous tumour thrombus, and metastasis, but limited accuracy for lymphadenopathy in RCC. Magnetic resonance imaging (MRI) is applied as a problem-solving modality, with particular strength in imaging metastasis to brain and bone. However, dynamic, contrast-enhanced- (DCE-) and arterial-spin-labelling (ASL-) MRI may help to monitor early response to angiogenesis inhibitor drugs. Ultrasonography (US) shows limited capability of identifying retroperitoneal disease, venous tumour thrombus extension, and metastasis. Positron Emission Tomography with 18-fluoro-desoxy-glucose (FDG-PET) demonstrates modest accuracy for metastasis of RCC, with positive studies being suspicious, while negative studies cannot reliably exclude disease. CONCLUSIONS: MDCT represents the diagnostic mainstay for the detection and staging of RCC. In the wake of new systemic therapies for advanced RCC, including angiogenesis inhibitor drugs, monitoring treatment response may become a new task for cross-sectional imaging.
Authors: C Catalano; F Fraioli; A Laghi; A Napoli; F Pediconi; M Danti; P Nardis; R Passariello Journal: AJR Am J Roentgenol Date: 2003-05 Impact factor: 3.959
Authors: Peter J Hallscheidt; Christian Fink; Axel Haferkamp; Michael Bock; Ante Luburic; Ivan Zuna; Gerd Noeldge; Guenter Kauffmann Journal: J Comput Assist Tomogr Date: 2005 Jan-Feb Impact factor: 1.826
Authors: Cedric de Bazelaire; David C Alsop; Daniel George; Ivan Pedrosa; Yongyu Wang; M Dror Michaelson; Neil M Rofsky Journal: Clin Cancer Res Date: 2008-09-01 Impact factor: 12.531
Authors: Narmada P Gupta; M S Ansari; Anurag Khaitan; M S Sivaramakrishna; Ashok K Hemal; P N Dogra; A Seth Journal: Urol Int Date: 2004 Impact factor: 2.089
Authors: Milan Hora; Petr Stránský; Ivan Trávníček; Tomáš Urge; Viktor Eret; Boris Kreuzberg; Jan Baxa; Hynek Mírka; Fredrik Petersson; Ondřej Hes; Jiří Ferda Journal: World J Urol Date: 2012-04-19 Impact factor: 4.226
Authors: Mohammad H Bagheri; Mark A Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A Malayeri; Piyush K Agarwal; Peter L Choyke; Les R Folio; Andrea B Apolo Journal: Urol Oncol Date: 2017-05-12 Impact factor: 3.498
Authors: Gita M Schoenberg; Viktoria Schuetz; Joanne N Nyarangi-Dix; Steffen J Diehl; Rafael Heiss; Boris Adamietz Journal: Urologe A Date: 2022-03-09 Impact factor: 0.639
Authors: Federica Sotgia; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Richard G Pestell; Michael P Lisanti Journal: Breast Cancer Res Date: 2011-07-08 Impact factor: 6.466